Gene name:
Ffar4 (Gpr120;O3far1) ;
Protein name:
Free fatty acid receptor 4 ;
Alternative:
G-protein coupled receptor GT01 ;G-protein coupled receptor 120 ;Omega-3 fatty acid receptor 1 ;
Organism:
Mouse (Mus musculus).
General Annotation
Sub Unit:
Interacts with ARRB2 following docosahexaenoic acid (DHA) stimulation.
Function:
Receptor for medium and long-chain free fatty acids (FFAs). Signals via a G(q)/G(11)-coupled pathway. Acts as a receptor for omega-3 fatty acids and mediates robust anti-inflammatory effects, particularly in macrophages and fat cells. The anti-inflammatory effects involve inhibition of TAK1 through a beta-arrestin 2 (ARRB2)/TAB1-dependent effect, but independent of the G(q)/G(11)-coupled pathway. Mediates potent insulin sensitizing and antidiabetic effects by repressing macrophage-induced tissue inflammation. Mediates the taste of fatty acids. Mediates FFA-induced inhibition of apoptosis in enteroendocrine cells. May play a role in the regulation of adipocyte development and differentiation.
Subcellular Location:
Cell membrane
Multi-pass membrane protein
Colocalized with ARRB2 following DHA treatment.
Protein Attributes:
50:
MSPECAQTTG | PGPSHTLDQV | NRTHFPFFSD | VKGDHRLVLS | VVETTVLGLI |
100:
FVVSLLGNVC | ALVLVARRRR | RGATASLVLN | LFCADLLFTS | AIPLVLVVRW |
150:
TEAWLLGPVV | CHLLFYVMTM | SGSVTILTLA | AVSLERMVCI | VRLRRGLSGP |
200:
GRRTQAALLA | FIWGYSALAA | LPLCILFRVV | PQRLPGGDQE | IPICTLDWPN |
250:
RIGEISWDVF | FVTLNFLVPG | LVIVISYSKI | LQITKASRKR | LTLSLAYSES |
300:
HQIRVSQQDY | RLFRTLFLLM | VSFFIMWSPI | IITILLILIQ | NFRQDLVIWP |
350:
SLFFWVVAFT | FANSALNPIL | YNMSLFRNEW | RKIFCCFFFP | EKGAIFTDTS |
Vaild Sequence:
Related Databases
Uniprot:
ELISA Kit
CLIA Kit
Polyclonal Antibody
Monoclonal Antibody
Protein
FOR
Rat
Human
Mouse
ELISA Kit for Mouse Free fatty acid receptor 4
ELISA Kit for Mouse Free fatty acid receptor 4
ELISA Kit for Mouse Free fatty acid receptor 4
CLIA Kit for Mouse Free fatty acid receptor 4
CLIA Kit for Mouse Free fatty acid receptor 4
CLIA Kit for Mouse Free fatty acid receptor 4
Polyclonal Antibody for Mouse Free fatty acid receptor 4
Polyclonal Antibody for Mouse Free fatty acid receptor 4
Polyclonal Antibody for Mouse Free fatty acid receptor 4
Monoclonal Antibody for Mouse Free fatty acid receptor 4
Monoclonal Antibody for Mouse Free fatty acid receptor 4
Monoclonal Antibody for Mouse Free fatty acid receptor 4
Protein for Mouse Free fatty acid receptor 4
Protein for Mouse Free fatty acid receptor 4
Protein for Mouse Free fatty acid receptor 4
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Precision
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Recovery
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Linearity
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
References
1.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA]
2.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA];TISSUE SPECIFICITY;FUNCTION
3.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]
strain :
FVB/N .
tissue :
Colon .
4.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : FUNCTION
5.
"The regulation of adipogenesis through GPR120."
Gotoh C.
,
Hong Y.H.
,
Iga T.
,
Hishikawa D.
,
Suzuki Y.
,
Song S.H.
,
Choi K.C.
,
Adachi T.
,
Hirasawa A.
,
Tsujimoto G.
,
Sasaki S.
,
Roh S.G.
Biochem. Biophys. Res. Commun.354:591-597(2007)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : FUNCTION;TISSUE SPECIFICITY;DEVELOPMENTAL STAGE;INDUCTION
6.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : TISSUE SPECIFICITY
7.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : FUNCTION;TISSUE SPECIFICITY;SUBCELLULAR LOCATION;DISRUPTION PHENOTYPE;INDUCTION
8.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : TISSUE SPECIFICITY;FUNCTION;DISRUPTION PHENOTYPE
9.
"Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human."
Ichimura A.
,
Hirasawa A.
,
Poulain-Godefroy O.
,
Bonnefond A.
,
Hara T.
,
Yengo L.
,
Kimura I.
,
Leloire A.
,
Liu N.
,
Iida K.
,
Choquet H.
,
Besnard P.
,
Lecoeur C.
,
Vivequin S.
,
Ayukawa K.
,
Takeuchi M.
,
Ozawa K.
,
Tauber M.
,
Maffeis C.
,
Morandi A.
,
Buzzetti R.
,
Elliott P.
,
Pouta A.
,
Jarvelin M.R.
,
Korner A.
,
Kiess W.
,
Pigeyre M.
,
Caiazzo R.
,
Van Hul W.
,
Van Gaal L.
,
Horber F.
,
Balkau B.
,
Levy-Marchal C.
,
Rouskas K.
,
Kouvatsi A.
,
Hebebrand J.
,
Hinney A.
,
Scherag A.
,
Pattou F.
,
Meyre D.
,
Koshimizu T.A.
,
Wolowczuk I.
,
Tsujimoto G.
,
Froguel P.
more...
Nature483:350-354(2012)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : DISRUPTION PHENOTYPE